This peptide was originally developed as a potent anti-obesity medication because of its lipolytic properties (fat-burning)
In: Therapeutic Guidelines
Currently, scientists have identified 15 types of B-thymosin, with thymosin Beta-4, or TB4, being the most abundant form
Great Potential in the Treatment of Metabolic Diseases With the high prevalence of metabolic diseases worldwide, 5-amino-1-methylquinolinium has shown outstanding performance in animal models of obesity, glucose metabolism disorders, fatty liver disease and other conditions
Special Populations Post-Bariatric Surgery Patients : Individuals who have undergone bariatric surgery, such as Roux-en-Y gastric bypass, are at a higher risk of vitamin B12 deficiency due to malabsorption